, a diversified health-care company involved in products and services, has shown impressive growth, with 12-month and three-month NOPAT growth of 52 and 11.7 per cent, respectively. While the NOPAT surged, the share price rose by a reasonable 28.3 per cent. Additionally, the company has maintained an average free-cash-flow to capital of 12.5 per cent, the highest of our screen. These robust metrics have contributed to a significant SP score of 82.
Investors are advised to do further research before investing in any of the companies listed in the accompanying table.For more details about these stocks, subscribe to the Inovestor for Advisors platform for free. Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter.